Biological and Computational Study of the Dual Antimicrobial and Anticancer Potential of 3,4‐Dihydropyrimidin‐2(1 H )‐ones and Thiones
ChemistrySelect · 2025-07 · 10 (26)
DOI: 10.1002/slct.202502768 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 10.07.2025. Verfasst von Natalia Ciobanu und 13 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Sixteen 3,4‐dihydropyrimidin‐2(1 H )‐ones and ‐thiones were synthesized and evaluated for antimicrobial activity against both resistant and nonresistant bacterial strains, as well as four fungal species. Antibacterial testing revealed MIC/MBC values ranging from 0.25 to 8.0 mg/mL, with compound 20 demonstrating the most potent activity (MIC: 0.42–2.0 mg/mL). Notably, compound 16 exhibited consistent efficacy against both resistant and nonresistant strains. Antifungal activity was assessed against Aspergillus fumigatus , Aspergillus niger , Penicillium funiculosum , and Candida albicans , with compound 20 again emerging as the most effective (MIC: 0.75–2.0 mg/mL). Compounds 16 and 25 also showed antibiofilm activity, with compound 16 inhibiting biofilm formation by 70.22%. Preliminary cytotoxicity screening against cancer cell lines indicated that several compounds exhibited moderate anticancer activity. ADMET (absorption, distribution, metabolism, excretion, and toxicity) analysis suggested favorable pharmacokinetic profiles, with no violations of Lipinski's Rule of Five. Molecular docking studies suggest that the antibacterial mechanism may involve inhibition of the MurB enzyme, while antifungal activity is likely mediated through inhibition of cytochrome P450 (CYP) enzymes.These findings underscore the potential of 3,4‐dihydropyrimidin‐2(1 H )‐(thi)ones as promising lead compounds for the development of novel antibacterial and antifungal agents.
Zitieren
APA
Ciobanu, N., Sucman, N., Petrou, A., Gorincioi, E., Valica, V., Uncu, L., Fesatidou, M., Glamočlij, J., Ivanov, M., Persoons, L., Schols, D., Jonghe, S. D., Geronikaki, A., & Macaev, F. (2025). Biological and Computational Study of the Dual Antimicrobial and Anticancer Potential of 3,4‐Dihydropyrimidin‐2(1 H )‐ones and Thiones. ChemistrySelect, 10(26). https://doi.org/10.1002/slct.202502768
Vancouver
Ciobanu N, Sucman N, Petrou A, Gorincioi E, Valica V, Uncu L, et al. Biological and Computational Study of the Dual Antimicrobial and Anticancer Potential of 3,4‐Dihydropyrimidin‐2(1 H )‐ones and Thiones. ChemistrySelect. 2025;10(26). doi:10.1002/slct.202502768
BibTeX
@article{Ciobanu2025,
author = {Ciobanu, Natalia and Sucman, Natalia and Petrou, Anthi and Gorincioi, Elena and Valica, Vladimir and Uncu, Livia and Fesatidou, Maria and Glamočlij, Jasmina and Ivanov, Marija and Persoons, Leentje and Schols, Dominique and Jonghe, Steven De and Geronikaki, Athina and Macaev, FliurZ.},
title = {Biological and Computational Study of the Dual Antimicrobial and Anticancer Potential of 3,4‐Dihydropyrimidin‐2(1 H )‐ones and Thiones},
journal = {ChemistrySelect},
year = {2025},
volume = {10},
number = {26},
doi = {10.1002/slct.202502768}
}
EUVIMED